Equity Profile

IQV

IQVIA Holdings Inc.

Health CareLife Sciences Tools & Services$34.6B

Jul21Tue

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing advanced analytics, technology solutions, and contract research services to life sciences companies....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability, and investors will be keen to see if IQVIA can maintain its strong performance.

N/A

Revenue Growth

Revenue growth indicates the company's ability to expand its business and capture market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

IQV Q2-2026 Earnings Preview

Context

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing advanced analytics, technology solutions, and contract research services to life sciences companies. As a key player in life sciences tools and services, IQVIA helps clients improve their research and development processes, making it an important contributor to the health care industry.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q1-2026, IQVIA reported an EPS of $2.90, exceeding expectations by 15.68%. The stock reacted positively, increasing by 9.62% the following day.

Management Promises & Guidance

Continued focus on enhancing technology solutions.
Commitment to expanding analytics capabilities.
Plans to strengthen partnerships within the life sciences sector.

Expectations

Wall Street Expectations

Overall, expectations are mixed as investors await clarity on revenue growth and profitability. The company has consistently beaten EPS estimates, but revenue figures remain uncertain.

Bull Case

If IQVIA continues its trend of beating EPS estimates and shows strong revenue growth, it could lead to significant stock appreciation.

Bear Case

On the other hand, if the company fails to meet revenue expectations or provides weak guidance, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the revenue growth rate be for this quarter?

Revenue growth is crucial for assessing the company's ability to expand and sustain its market position, and any shortfall could impact investor confidence.

Will management provide guidance for the upcoming quarters?

Guidance is essential for setting expectations and can significantly influence stock performance, especially if it deviates from analyst forecasts.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating IQVIA's potential for revenue growth due to its strong analytics capabilities, which could drive demand in the life sciences sector.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a larger expected move than historical averages, indicating heightened investor interest.

Key Risk

If revenue growth exceeds 10%, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether IQVIA can sustain its growth trajectory amidst increasing competition and market pressures.

Bull Confirmed If

Revenue growth of 10% or more compared to the previous quarter would confirm the bull case.

Bear Confirmed If

A revenue growth rate below 5% would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±16.03%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±16.0% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

51.6%

Calls (204K)P/C Ratio: 0.32Puts (69K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations and raises guidance, history suggests the stock could rise by around 2.48% on the first day.

In-Line / Cautious

If results are in line but management is cautious, the stock may experience a muted reaction, reflecting uncertainty in future growth.

Miss

If the company misses expectations, history suggests a potential decline of around 4.01% on the first day.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$50,001.00–$100,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new technology partnerships that could enhance service offerings.
2Details on revenue growth in specific segments, particularly analytics.
3Management's outlook on market conditions and competitive landscape.
4Insights into customer retention and acquisition strategies.
5Any commentary on cost management and efficiency improvements.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

ICICI Bank Limited

Company Snapshot

IQVIA Holdings Inc. operates in the health care sector, providing advanced analytics, technology solutions, and contract research services to life sciences companies....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a critical measure of profitability, and investors will be keen to see if IQVIA can maintain its strong performance.

N/A

Revenue Growth

Revenue growth indicates the company's ability to expand its business and capture market share, which is vital for long-term success.

N/A

Wall Street expectations, options signals, track record, and call prep available with Pro.

IQV Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

100%

Avg EPS Surprise

+11.71%

Avg Stock Reaction

+2.48%

Last Quarter Recap

In Q1-2026, IQVIA reported an EPS of $2.90, exceeding expectations by 15.68%. The stock reacted positively, increasing by 9.62% the following day.

Management Promises & Guidance

Continued focus on enhancing technology solutions.
Commitment to expanding analytics capabilities.
Plans to strengthen partnerships within the life sciences sector.

Expectations

Wall Street Expectations

Overall, expectations are mixed as investors await clarity on revenue growth and profitability. The company has consistently beaten EPS estimates, but revenue figures remain uncertain.

Bull Case

If IQVIA continues its trend of beating EPS estimates and shows strong revenue growth, it could lead to significant stock appreciation.

Bear Case

On the other hand, if the company fails to meet revenue expectations or provides weak guidance, it could lead to a sharp decline in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will the revenue growth rate be for this quarter?

Revenue growth is crucial for assessing the company's ability to expand and sustain its market position, and any shortfall could impact investor confidence.

Will management provide guidance for the upcoming quarters?

Guidance is essential for setting expectations and can significantly influence stock performance, especially if it deviates from analyst forecasts.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may be underestimating IQVIA's potential for revenue growth due to its strong analytics capabilities, which could drive demand in the life sciences sector.

Supporting Evidence

The company has consistently beaten EPS estimates, indicating strong operational performance.

Options pricing suggests a larger expected move than historical averages, indicating heightened investor interest.

Key Risk

If revenue growth exceeds 10%, it could challenge the current cautious consensus.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

The market is debating whether IQVIA can sustain its growth trajectory amidst increasing competition and market pressures.

Bull Confirmed If

Revenue growth of 10% or more compared to the previous quarter would confirm the bull case.

Bear Confirmed If

A revenue growth rate below 5% would support the bear case.

Pre-Earnings Positioning

Options Market

Implied Move

±16.03%

Historical Avg

±7.3%

Pricing rich

The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.

Options are pricing ±16.0% while IQV has averaged ±7.3% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

51.6%

Calls (204K)P/C Ratio: 0.32Puts (69K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If IQVIA beats expectations and raises guidance, history suggests the stock could rise by around 2.48% on the first day.

In-Line / Cautious

If results are in line but management is cautious, the stock may experience a muted reaction, reflecting uncertainty in future growth.

Miss

If the company misses expectations, history suggests a potential decline of around 4.01% on the first day.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

0 buys·1 sell

Members

House only

Est. Notional

$50,001.00–$100,000.00

disclosed dollar ranges

Most Active Members

R-OKKevin HernRep.
1

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new technology partnerships that could enhance service offerings.
2Details on revenue growth in specific segments, particularly analytics.
3Management's outlook on market conditions and competitive landscape.
4Insights into customer retention and acquisition strategies.
5Any commentary on cost management and efficiency improvements.